Global mAb Biosimilar Market Research Report 2016

October 2016 | 113 pages | ID: G7E7F95D6CFEN
QYResearch

Abstracts

Notes:

Production, means the output of mAb Biosimilar

Revenue, means the sales value of mAb Biosimilar

This report studies mAb Biosimilar in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, focuses on top manufacturers in global market, with Production, price, revenue and market share for each manufacturer, covering

• Baxter
• GSK
• Merck
• Novartis
• Pfizer
• Roche Holding
• Sanofi
• Mitsubishi Tanabe Pharma
• Hospira
• Alvartis Pharma
• Allergan
• Amega Biotech
• Biogen
• LG Lifesciences
• Samsung Biologics

Market Segment by Regions, this report splits Global into several key Regions, with production, consumption, revenue, market share and growth rate of mAb Biosimilar in these regions, from 2011 to 2021 (forecast), like

• North America
• Europe
• China
• Japan
• Southeast Asia
• India

Split by product type, with production, revenue, price, market share and growth rate of each type, can be divided into

• Type I
• Type II
• Type III

Split by application, this report focuses on consumption, market share and growth rate of mAb Biosimilar in each application, can be divided into

• Application 1
• Application 2
• Application 3

Contents

Global mAb Biosimilar Market Research Report 2016

1 MAB BIOSIMILAR MARKET OVERVIEW

1.1 Product Overview and Scope of mAb Biosimilar
1.2 mAb Biosimilar Segment by Type
  1.2.1 Global Production Market Share of mAb Biosimilar by Type in 2015
  1.2.2 Type I
  1.2.3 Type II
  1.2.4 Type III
1.3 mAb Biosimilar Segment by Application
  1.3.1 mAb Biosimilar Consumption Market Share by Application in 2015
  1.3.2 Application
  1.3.3 Application
  1.3.4 Application
1.4 mAb Biosimilar Market by Region
  1.4.1 North America Status and Prospect (2011-2021)
  1.4.2 Europe Status and Prospect (2011-2021)
  1.4.3 China Status and Prospect (2011-2021)
  1.4.4 Japan Status and Prospect (2011-2021)
  1.4.5 Southeast Asia Status and Prospect (2011-2021)
  1.4.6 India Status and Prospect (2011-2021)
1.5 Global Market Size (Value) of mAb Biosimilar (2011-2021)

2 GLOBAL MAB BIOSIMILAR MARKET COMPETITION BY MANUFACTURERS

2.1 Global mAb Biosimilar Production and Share by Manufacturers (2015 and 2016)
2.2 Global mAb Biosimilar Revenue and Share by Manufacturers (2015 and 2016)
2.3 Global mAb Biosimilar Average Price by Manufacturers (2015 and 2016)
2.4 Manufacturers mAb Biosimilar Manufacturing Base Distribution, Sales Area and Product Type
2.5 mAb Biosimilar Market Competitive Situation and Trends
  2.5.1 mAb Biosimilar Market Concentration Rate
  2.5.2 mAb Biosimilar Market Share of Top 3 and Top 5 Manufacturers
  2.5.3 Mergers & Acquisitions, Expansion

3 GLOBAL MAB BIOSIMILAR PRODUCTION, REVENUE (VALUE) BY REGION (2011-2016)

3.1 Global mAb Biosimilar Production and Market Share by Region (2011-2016)
3.2 Global mAb Biosimilar Revenue (Value) and Market Share by Region (2011-2016)
3.3 Global mAb Biosimilar Production, Revenue, Price and Gross Margin (2011-2016)
3.4 North America mAb Biosimilar Production, Revenue, Price and Gross Margin (2011-2016)
3.5 Europe mAb Biosimilar Production, Revenue, Price and Gross Margin (2011-2016)
3.6 China mAb Biosimilar Production, Revenue, Price and Gross Margin (2011-2016)
3.7 Japan mAb Biosimilar Production, Revenue, Price and Gross Margin (2011-2016)
3.8 Southeast Asia mAb Biosimilar Production, Revenue, Price and Gross Margin (2011-2016)
3.9 India mAb Biosimilar Production, Revenue, Price and Gross Margin (2011-2016)

4 GLOBAL MAB BIOSIMILAR SUPPLY (PRODUCTION), CONSUMPTION, EXPORT, IMPORT BY REGIONS (2011-2016)

4.1 Global mAb Biosimilar Consumption by Regions (2011-2016)
4.2 North America mAb Biosimilar Production, Consumption, Export, Import by Regions (2011-2016)
4.3 Europe mAb Biosimilar Production, Consumption, Export, Import by Regions (2011-2016)
4.4 China mAb Biosimilar Production, Consumption, Export, Import by Regions (2011-2016)
4.5 Japan mAb Biosimilar Production, Consumption, Export, Import by Regions (2011-2016)
4.6 Southeast Asia mAb Biosimilar Production, Consumption, Export, Import by Regions (2011-2016)
4.7 India mAb Biosimilar Production, Consumption, Export, Import by Regions (2011-2016)

5 GLOBAL MAB BIOSIMILAR PRODUCTION, REVENUE (VALUE), PRICE TREND BY TYPE

5.1 Global mAb Biosimilar Production and Market Share by Type (2011-2016)
5.2 Global mAb Biosimilar Revenue and Market Share by Type (2011-2016)
5.3 Global mAb Biosimilar Price by Type (2011-2016)
5.4 Global mAb Biosimilar Production Growth by Type (2011-2016)

6 GLOBAL MAB BIOSIMILAR MARKET ANALYSIS BY APPLICATION

6.1 Global mAb Biosimilar Consumption and Market Share by Application (2011-2016)
6.2 Global mAb Biosimilar Consumption Growth Rate by Application (2011-2016)
6.3 Market Drivers and Opportunities
  6.3.1 Potential Applications
  6.3.2 Emerging Markets/Countries

7 GLOBAL MAB BIOSIMILAR MANUFACTURERS PROFILES/ANALYSIS

7.1 Baxter
  7.1.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.1.2 mAb Biosimilar Product Type, Application and Specification
    7.1.2.1 Type I
    7.1.2.2 Type II
  7.1.3 Baxter mAb Biosimilar Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.1.4 Main Business/Business Overview
7.2 GSK
  7.2.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.2.2 mAb Biosimilar Product Type, Application and Specification
    7.2.2.1 Type I
    7.2.2.2 Type II
  7.2.3 GSK mAb Biosimilar Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.2.4 Main Business/Business Overview
7.3 Merck
  7.3.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.3.2 mAb Biosimilar Product Type, Application and Specification
    7.3.2.1 Type I
    7.3.2.2 Type II
  7.3.3 Merck mAb Biosimilar Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.3.4 Main Business/Business Overview
7.4 Novartis
  7.4.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.4.2 mAb Biosimilar Product Type, Application and Specification
    7.4.2.1 Type I
    7.4.2.2 Type II
  7.4.3 Novartis mAb Biosimilar Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.4.4 Main Business/Business Overview
7.5 Pfizer
  7.5.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.5.2 mAb Biosimilar Product Type, Application and Specification
    7.5.2.1 Type I
    7.5.2.2 Type II
  7.5.3 Pfizer mAb Biosimilar Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.5.4 Main Business/Business Overview
7.6 Roche Holding
  7.6.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.6.2 mAb Biosimilar Product Type, Application and Specification
    7.6.2.1 Type I
    7.6.2.2 Type II
  7.6.3 Roche Holding mAb Biosimilar Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.6.4 Main Business/Business Overview
7.7 Sanofi
  7.7.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.7.2 mAb Biosimilar Product Type, Application and Specification
    7.7.2.1 Type I
    7.7.2.2 Type II
  7.7.3 Sanofi mAb Biosimilar Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.7.4 Main Business/Business Overview
7.8 Mitsubishi Tanabe Pharma
  7.8.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.8.2 mAb Biosimilar Product Type, Application and Specification
    7.8.2.1 Type I
    7.8.2.2 Type II
  7.8.3 Mitsubishi Tanabe Pharma mAb Biosimilar Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.8.4 Main Business/Business Overview
7.9 Hospira
  7.9.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.9.2 mAb Biosimilar Product Type, Application and Specification
    7.9.2.1 Type I
    7.9.2.2 Type II
  7.9.3 Hospira mAb Biosimilar Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.9.4 Main Business/Business Overview
7.10 Alvartis Pharma
  7.10.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.10.2 mAb Biosimilar Product Type, Application and Specification
    7.10.2.1 Type I
    7.10.2.2 Type II
  7.10.3 Alvartis Pharma mAb Biosimilar Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.10.4 Main Business/Business Overview
7.11 Allergan
7.12 Amega Biotech
7.13 Biogen
7.14 LG Lifesciences
7.15 Samsung Biologics

8 MAB BIOSIMILAR MANUFACTURING COST ANALYSIS

8.1 mAb Biosimilar Key Raw Materials Analysis
  8.1.1 Key Raw Materials
  8.1.2 Price Trend of Key Raw Materials
  8.1.3 Key Suppliers of Raw Materials
  8.1.4 Market Concentration Rate of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
  8.2.1 Raw Materials
  8.2.2 Labor Cost
  8.2.3 Manufacturing Expenses
8.3 Manufacturing Process Analysis of mAb Biosimilar

9 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

9.1 mAb Biosimilar Industrial Chain Analysis
9.2 Upstream Raw Materials Sourcing
9.3 Raw Materials Sources of mAb Biosimilar Major Manufacturers in 2015
9.4 Downstream Buyers

10 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

10.1 Marketing Channel
  10.1.1 Direct Marketing
  10.1.2 Indirect Marketing
  10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
  10.2.1 Pricing Strategy
  10.2.2 Brand Strategy
  10.2.3 Target Client
10.3 Distributors/Traders List

11 MARKET EFFECT FACTORS ANALYSIS

11.1 Technology Progress/Risk
  11.1.1 Substitutes Threat
  11.1.2 Technology Progress in Related Industry
11.2 Consumer Needs/Customer Preference Change
11.3 Economic/Political Environmental Change

12 GLOBAL MAB BIOSIMILAR MARKET FORECAST (2016-2021)

12.1 Global mAb Biosimilar Production, Revenue Forecast (2016-2021)
12.2 Global mAb Biosimilar Production, Consumption Forecast by Regions (2016-2021)
12.3 Global mAb Biosimilar Production Forecast by Type (2016-2021)
12.4 Global mAb Biosimilar Consumption Forecast by Application (2016-2021)
12.5 mAb Biosimilar Price Forecast (2016-2021)

13 RESEARCH FINDINGS AND CONCLUSION

14 APPENDIX

Author List
Disclosure Section
Research Methodology
Data Source
China Disclaimer

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of mAb Biosimilar
Figure Global Production Market Share of mAb Biosimilar by Type in 2015
Figure Product Picture of Type I
Table Major Manufacturers of Type I
Figure Product Picture of Type II
Table Major Manufacturers of Type II
Figure Product Picture of Type III
Table Major Manufacturers of Type III
Table mAb Biosimilar Consumption Market Share by Application in 2015
Figure Application 1 Examples
Figure Application 2 Examples
Figure Application 3 Examples
Figure North America mAb Biosimilar Revenue (Million USD) and Growth Rate (2011-2021)
Figure Europe mAb Biosimilar Revenue (Million USD) and Growth Rate (2011-2021)
Figure China mAb Biosimilar Revenue (Million USD) and Growth Rate (2011-2021)
Figure Japan mAb Biosimilar Revenue (Million USD) and Growth Rate (2011-2021)
Figure Southeast Asia mAb Biosimilar Revenue (Million USD) and Growth Rate (2011-2021)
Figure India mAb Biosimilar Revenue (Million USD) and Growth Rate (2011-2021)
Figure Global mAb Biosimilar Revenue (Million UDS) and Growth Rate (2011-2021)
Table Global mAb Biosimilar Production of Key Manufacturers (2015 and 2016)
Table Global mAb Biosimilar Production Share by Manufacturers (2015 and 2016)
Figure 2015 mAb Biosimilar Production Share by Manufacturers
Figure 2016 mAb Biosimilar Production Share by Manufacturers
Table Global mAb Biosimilar Revenue (Million USD) by Manufacturers (2015 and 2016)
Table Global mAb Biosimilar Revenue Share by Manufacturers (2015 and 2016)
Table 2015 Global mAb Biosimilar Revenue Share by Manufacturers
Table 2016 Global mAb Biosimilar Revenue Share by Manufacturers
Table Global Market mAb Biosimilar Average Price of Key Manufacturers (2015 and 2016)
Figure Global Market mAb Biosimilar Average Price of Key Manufacturers in 2015
Table Manufacturers mAb Biosimilar Manufacturing Base Distribution and Sales Area
Table Manufacturers mAb Biosimilar Product Type
Figure mAb Biosimilar Market Share of Top 3 Manufacturers
Figure mAb Biosimilar Market Share of Top 5 Manufacturers
Table Global mAb Biosimilar Production by Regions (2011-2016)
Figure Global mAb Biosimilar Production and Market Share by Regions (2011-2016)
Figure Global mAb Biosimilar Production Market Share by Regions (2011-2016)
Figure 2015 Global mAb Biosimilar Production Market Share by Regions
Table Global mAb Biosimilar Revenue by Regions (2011-2016)
Table Global mAb Biosimilar Revenue Market Share by Regions (2011-2016)
Table 2015 Global mAb Biosimilar Revenue Market Share by Regions
Table Global mAb Biosimilar Production, Revenue, Price and Gross Margin (2011-2016)
Table North America mAb Biosimilar Production, Revenue, Price and Gross Margin (2011-2016)
Table Europe mAb Biosimilar Production, Revenue, Price and Gross Margin (2011-2016)
Table China mAb Biosimilar Production, Revenue, Price and Gross Margin (2011-2016)
Table Japan mAb Biosimilar Production, Revenue, Price and Gross Margin (2011-2016)
Table Southeast Asia mAb Biosimilar Production, Revenue, Price and Gross Margin (2011-2016)
Table India mAb Biosimilar Production, Revenue, Price and Gross Margin (2011-2016)
Table Global mAb Biosimilar Consumption Market by Regions (2011-2016)
Table Global mAb Biosimilar Consumption Market Share by Regions (2011-2016)
Figure Global mAb Biosimilar Consumption Market Share by Regions (2011-2016)
Figure 2015 Global mAb Biosimilar Consumption Market Share by Regions
Table North America mAb Biosimilar Production, Consumption, Import & Export (2011-2016)
Table Europe mAb Biosimilar Production, Consumption, Import & Export (2011-2016)
Table China mAb Biosimilar Production, Consumption, Import & Export (2011-2016)
Table Japan mAb Biosimilar Production, Consumption, Import & Export (2011-2016)
Table Southeast Asia mAb Biosimilar Production, Consumption, Import & Export (2011-2016)
Table India mAb Biosimilar Production, Consumption, Import & Export (2011-2016)
Table Global mAb Biosimilar Production by Type (2011-2016)
Table Global mAb Biosimilar Production Share by Type (2011-2016)
Figure Production Market Share of mAb Biosimilar by Type (2011-2016)
Figure 2015 Production Market Share of mAb Biosimilar by Type
Table Global mAb Biosimilar Revenue by Type (2011-2016)
Table Global mAb Biosimilar Revenue Share by Type (2011-2016)
Figure Production Revenue Share of mAb Biosimilar by Type (2011-2016)
Figure 2015 Revenue Market Share of mAb Biosimilar by Type
Table Global mAb Biosimilar Price by Type (2011-2016)
Figure Global mAb Biosimilar Production Growth by Type (2011-2016)
Table Global mAb Biosimilar Consumption by Application (2011-2016)
Table Global mAb Biosimilar Consumption Market Share by Application (2011-2016)
Figure Global mAb Biosimilar Consumption Market Share by Application in 2015
Table Global mAb Biosimilar Consumption Growth Rate by Application (2011-2016)
Figure Global mAb Biosimilar Consumption Growth Rate by Application (2011-2016)
Table Baxter Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Baxter mAb Biosimilar Production, Revenue, Price and Gross Margin (2011-2016)
Figure Baxter mAb Biosimilar Market Share (2011-2016)
Table GSK Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table GSK mAb Biosimilar Production, Revenue, Price and Gross Margin (2011-2016)
Figure GSK mAb Biosimilar Market Share (2011-2016)
Table Merck Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Merck mAb Biosimilar Production, Revenue, Price and Gross Margin (2011-2016)
Figure Merck mAb Biosimilar Market Share (2011-2016)
Table Novartis Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Novartis mAb Biosimilar Production, Revenue, Price and Gross Margin (2011-2016)
Figure Novartis mAb Biosimilar Market Share (2011-2016)
Table Pfizer Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Pfizer mAb Biosimilar Production, Revenue, Price and Gross Margin (2011-2016)
Figure Pfizer mAb Biosimilar Market Share (2011-2016)
Table Roche Holding Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Roche Holding mAb Biosimilar Production, Revenue, Price and Gross Margin (2011-2016)
Figure Roche Holding mAb Biosimilar Market Share (2011-2016)
Table Sanofi Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Sanofi mAb Biosimilar Production, Revenue, Price and Gross Margin (2011-2016)
Figure Sanofi mAb Biosimilar Market Share (2011-2016)
Table Mitsubishi Tanabe Pharma Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Mitsubishi Tanabe Pharma mAb Biosimilar Production, Revenue, Price and Gross Margin (2011-2016)
Figure Mitsubishi Tanabe Pharma mAb Biosimilar Market Share (2011-2016)
Table Hospira Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Hospira mAb Biosimilar Production, Revenue, Price and Gross Margin (2011-2016)
Figure Hospira mAb Biosimilar Market Share (2011-2016)
Table Alvartis Pharma Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Alvartis Pharma mAb Biosimilar Production, Revenue, Price and Gross Margin (2011-2016)
Figure Alvartis Pharma mAb Biosimilar Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of mAb Biosimilar
Figure Manufacturing Process Analysis of mAb Biosimilar
Figure mAb Biosimilar Industrial Chain Analysis
Table Raw Materials Sources of mAb Biosimilar Major Manufacturers in 2015
Table Major Buyers of mAb Biosimilar
Table Distributors/Traders List
Figure Global mAb Biosimilar Production and Growth Rate Forecast (2016-2021)
Figure Global mAb Biosimilar Revenue and Growth Rate Forecast (2016-2021)
Table Global mAb Biosimilar Production Forecast by Regions (2016-2021)
Table Global mAb Biosimilar Consumption Forecast by Regions (2016-2021)
Table Global mAb Biosimilar Production Forecast by Type (2016-2021)
Table Global mAb Biosimilar Consumption Forecast by Application (2016-2021)